| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ocriplasmin | alpha-2-macroglobulin | biotech | NA | drugbank | Tissue Adhesions[MeSHID:D000267] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | ligand |
| ocriplasmin | fibronectin | biotech | Clinical trial target | TTD , drugbank , DGIDB | Tissue Adhesions[MeSHID:D000267] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.29 | approved | cleavage |
| ocriplasmin | alpha-2-antiplasmin | biotech | NA | drugbank | Tissue Adhesions[MeSHID:D000267] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | ligand |
| click here to return to the previous page | ||||||||